Walgreens 2014 Annual Report Download - page 107

Download and view the complete annual report

Please find page 107 of the 2014 Walgreens annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Item 14. Principal Accounting Fees and Services
The information required by Item 14 is incorporated herein by reference to the following sections of the
Company’s Proxy Statement: Independent Registered Public Accounting Firm Fees and Services, or will be
included in an amendment to this Form 10-K.
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) Documents filed as part of this report:
(1) Financial statements. The following financial statements, supplementary data, and reports of
independent public accountants appearing in Part II, Item 8 of this Form 10-K and are incorporated
herein by reference.
Consolidated Statements of Earnings, Comprehensive Income and Shareholders’ Equity for the years ended
August 31, 2014, 2013 and 2012
Consolidated Balance Sheets at August 31, 2014 and 2013
Consolidated Statements of Cash Flows for the years ended August 31, 2014, 2013 and 2012
Notes to Consolidated Financial Statements
Management’s Report on Internal Control
Reports of Independent Registered Public Accounting Firms
(2) Financial statement schedules and supplementary information
Schedules I, II, III, IV and V are not submitted because they are not applicable or not required or
because the required information is included in the Financial Statements referenced in (1) above or the
notes thereto.
Other Financial Statements -
Separate financial statements of the registrant have been omitted because it is primarily an operating
company, and all of its subsidiaries are included in the consolidated financial statements.
Alliance Boots GmbH
On August 2, 2012, we completed a 45% equity investment in Alliance Boots GmbH that we account
for using the equity method of accounting. SEC Rule 3-09 of Regulation S-X requires that we include
or incorporate by reference Alliance Boots GmbH financial statements in this Form 10-K if our
investment was considered to be significant in the context of Rule 3-09 for the year ended August 31,
2014. Alliance Boots GmbH audited consolidated financial statements and accompanying notes
(prepared in accordance with IFRS and audited in accordance with U.S. GAAS), including the
statements of financial position at March 31, 2014 and 2013 of Alliance Boots and its subsidiaries (the
Group) and the related Group income statements, Group statements of comprehensive income, Group
statements of changes in equity and Group statements of cash flows for each of the years in the three-
year period ended March 31, 2014 are filed as Exhibit 99.1 hereto and incorporated herein by
reference.
(3) Exhibits. Exhibits 10.1 through 10.66 constitute management contracts or compensatory plans or
arrangements required to be filed as exhibits pursuant to Item 15(b) of this Form 10-K.
The agreements included as exhibits to this report are included to provide information regarding their
terms and not intended to provide any other factual or disclosure information about the Company or the
99